STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering

Core Points - STRATA Skin Sciences, Inc. has successfully closed a registered direct offering, issuing 1,097,547 shares of common stock at a price of $2.204 per share [1][2] - The gross proceeds from this offering amounted to approximately $2.42 million, which will be utilized for working capital and general corporate purposes [2] - The offering was conducted under a shelf registration statement declared effective by the SEC on December 18, 2024, with a prospectus supplement filed on September 3, 2025 [3] Company Overview - STRATA Skin Sciences is focused on developing, commercializing, and marketing innovative products for treating dermatologic conditions, including psoriasis, vitiligo, and acne [4] - The company's product lineup features the XTRAC excimer laser, VTRAC lamp systems, and the TheraClearX Acne Therapy System [4] - STRATA employs a unique Partnership Program that offers a fee per treatment cost structure, on-site training, service and maintenance, and co-op advertising support [5]